NCT05476965 Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma Status UNKNOWN Phase PHASE2
NCT05472506 Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer Status WITHDRAWN Phase PHASE1
NCT05457478 The Use of "Smart" Body-Weight Scales for Weight and Nutritional Monitoring in Patients With Head and Neck Cancer Undergoing Radiation Therapy Status TERMINATED Phase NA
NCT05451576 Sodium Selenite Supplementation in Patients With Head and Neck Cancer Status UNKNOWN Phase NA
NCT05446467 Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC Status RECRUITING Phase PHASE2
NCT05437380 Peritumoral Microbubbles and CEUS for SLN Detection and Biopsy in HNSCC Status RECRUITING Phase NA
NCT05433116 Pembrolizumab and Lenvatinib After Definitive Chemoradiation of Locally Advanced HNSCC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05432193 FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) Status TERMINATED Phase PHASE1
NCT05420948 A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT05412875 Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung Status WITHDRAWN Phase NA
NCT05400239 SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome Status RECRUITING Phase N/A
NCT05364411 HYpofractionated, Dose-redistributed RAdiotherapy With Protons and Photons in HNSCC Status RECRUITING Phase NA
NCT05363605 A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours Status TERMINATED Phase PHASE1/PHASE2
NCT05351762 Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC Status UNKNOWN Phase PHASE2
NCT05343325 The Efficacy and Safety of Neoadjuvant Low-dose Radiotherapy Combined With Chemoimmunotherapy in Locally Advanced HNSCC Status RECRUITING Phase PHASE2
NCT05338905 Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial Status ACTIVE_NOT_RECRUITING Phase NA
NCT05322135 A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma Status TERMINATED Phase EARLY_PHASE1
NCT05299203 BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma) Status UNKNOWN Phase PHASE1
NCT05296135 Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell Cancer Status WITHDRAWN Phase N/A